PSE (Pseudoephedrine)

Browse PSE (Pseudoephedrine) Content

The purpose of this cybersecurity and data privacy regulatory scan is to understand the current and forthcoming regulatory landscape related to cybersecurity and consumer data privacy.

Jan 20, 2023

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Sep 8, 2021

Oregon has repealed a 15-year-old law that banned OTC sales of certain medicines for colds and allergies containing PSE.

Jun 17, 2021

Now from coast-to-coast, it is once again legal to purchase cold and allergy medicines containing the decongestant pseudoephedrine (PSE) over-the-counter (OTC). In a major victory for consumers, Oregon has repealed a 15-year-old law that banned OTC sales of certain medicines for colds and allergies containing PSE.

Jun 17, 2021

On Tuesday, April 13, the Oregon House Committee on Health Care voted unanimously to advance H.B. 2648 to the full House of Representatives for a vote.

Apr 14, 2021

This week, the House Energy and Commerce Health Subcommittee is holding a hearing, entitled: "An Epidemic within a Pandemic: Understanding Substance Use and Misuse in America."

Apr 14, 2021

On Wednesday, March 17, Mississippi Governor Tate Reeves signed S.B. 2119, repealing a law that overturns the state’s ban of over-the-counter (OTC) sales of pseudoephedrine (PSE).

Mar 18, 2021

The new law returns PSE to OTC status allowing consumers to purchase 3.6 grams of PSE per day, up to 7.2 grams per month.

Mar 17, 2021

Filter Results